The study’s central innovation lies in its timing. Most previous research on infection and heart defects has focused on infections contracted during pregnancy, particularly in the first trimester when the embryonic heart is forming. This new analysis shifts the window backward, asking whether the state of a woman’s immune system and reproductive tract before she conceives might also shape her child’s cardiac risk. The investigators assessed two broad categories of preconception exposure. The first comprised active reproductive tract infections, specifically candidiasis and Chlamydia trachomatis infection, diagnosed at the preconception examination. The second comprised immunoglobulin G seropositivity to three well-known pathogens: cytomegalovirus, Toxoplasma gondii, and rubella virus. Immunoglobulin G antibodies indicate prior exposure to a pathogen and persist in the blood for years, so seropositivity serves as a marker of a woman’s immunological history rather than of an active acute illness at the time of testing.

The data came from China’s National Free Preconception Health Examination Project, a government program that offers voluntary health screening to couples planning marriage or pregnancy. All participants provided written informed consent, and the retrospective analysis of anonymized records was approved by the Institutional Review Board of Guangdong Women and Children Hospital. Because the screening program covers a defined population rather than a selected sample of hospital patients, the cohort reflects a broad cross-section of women of reproductive age in one of China’s most populous provinces, which strengthens the generalizability of the findings within similar settings.

Statistically, the team used multivariable modified Poisson regression with robust error variance, a modeling approach widely favored in epidemiology when the outcome of interest is relatively common and researchers want to estimate relative risks directly rather than odds ratios, which can overstate risk in such settings. The models adjusted for potential confounding factors, and the authors reported both adjusted relative risks and risk differences per 1,000 births, each accompanied by 95 percent confidence intervals. The primary outcome, congenital heart disease, was ascertained from the birth defects registry, providing a standardized and population-wide mechanism for capturing diagnoses rather than relying on self-report or single-hospital records.

The results were striking across the board. Chlamydia trachomatis infection detected before conception was associated with an adjusted relative risk of 1.89, meaning the risk of congenital heart disease in offspring was nearly doubled among exposed women, with a confidence interval of 1.14 to 3.15. Even more pronounced was the association with cytomegalovirus IgG seropositivity, which carried an adjusted relative risk of 2.70, with a confidence interval of 2.26 to 3.22. Candidiasis was linked to an adjusted relative risk of 1.50, rubella IgG seropositivity to 1.59, and Toxoplasma gondii IgG seropositivity to 1.32, all with confidence intervals excluding the null value of 1. In other words, every one of the five preconception infection-related exposures examined showed a statistically significant association with elevated offspring heart defect risk in the fully adjusted models.

Perhaps the most eye-catching numbers emerged when the researchers examined women exposed to more than one factor. Among women with both Chlamydia trachomatis infection and cytomegalovirus IgG seropositivity, the adjusted relative risk reached 5.14, with a confidence interval of 2.92 to 9.06. Women with candidiasis combined with cytomegalovirus IgG seropositivity showed an adjusted relative risk of 3.72, with a confidence interval of 2.53 to 5.49. These joint-exposure estimates suggest that women carrying multiple infection-related markers before conception may face substantially higher absolute risks than those with any single marker. However, the authors are careful to frame these findings appropriately: the elevated estimates in jointly exposed groups describe joint exposure patterns and should not be interpreted as evidence of biological interaction, meaning the study cannot establish that the two exposures amplify each other’s effects at a mechanistic level.

The biological plausibility of a link between maternal infection and fetal cardiac development has a long scientific pedigree. Congenital heart disease arises from disruptions in the intricate choreography of embryonic heart formation, which occurs largely within the first eight weeks of gestation. Maternal immune activation, whether triggered by active infection or by the lingering immunological landscape left by past pathogens, is thought in some contexts to influence early embryonic environments through inflammatory signaling, altered cytokine profiles, and effects on placental development. Rubella is a classic and well-established teratogen, capable of causing a constellation of congenital defects including cardiac anomalies when infection occurs in early pregnancy. Cytomegalovirus, the most common congenital infection worldwide, and Toxoplasma gondii, a parasite transmitted through undercooked meat or contact with cat feces, are both recognized causes of congenital disease, though their specific contribution to structural heart defects has been less clearly quantified. This study adds a preconception dimension to that picture, suggesting that the immunological terrain established before pregnancy may matter as much as events during gestation.

The methodological strengths of the study deserve emphasis. With more than 630,000 pregnancies and over 1,300 outcome cases, the analysis had the statistical power to detect associations of modest magnitude that smaller studies would miss. The prospective timing of the exposure assessment is another advantage: infection status and serology were measured at preconception examinations, before any pregnancy outcome was known, which reduces the risk of recall bias and reverse causation that plague studies relying on postnatal reporting. The use of a birth defects registry for outcome ascertainment provides systematic case identification across the province. Sensitivity analyses, in which the researchers re-ran their models under alternative assumptions, produced results consistent with the primary findings, adding confidence that the associations are not artifacts of particular modeling choices.

At the same time, the authors and readers alike must weigh the inherent limits of observational research. An association, however robust, does not prove causation. Seropositivity to cytomegalovirus, rubella, and Toxoplasma gondii reflects past exposure and may correlate with unmeasured characteristics, such as socioeconomic conditions, occupational exposures, dietary patterns, or broader immune profiles, that could themselves influence cardiac development risk. The study was conducted in a single province of China, and seroprevalence of these pathogens varies considerably across regions and income settings, so the absolute risks and even the magnitude of associations may differ elsewhere. The authors also note that the published version was shared early as a citable, peer-reviewed accepted manuscript subject to further editorial refinement, a reminder that details may be updated in the final version of record.

Even with those caveats, the public health implications are considerable. Congenital heart disease imposes a lifelong burden on affected children and families, often requiring surgery, ongoing cardiology care, and in severe cases resulting in early mortality. If preconception infection status genuinely contributes to risk, then the period before pregnancy becomes a critical and currently underused window for intervention. Screening and treating chlamydial infections and candidiasis before conception, counseling women on toxoplasmosis prevention, and ensuring rubella immunity through vaccination well ahead of pregnancy are all established, low-cost measures already embedded in many preconception care frameworks. The findings from Guangdong suggest that such measures may carry benefits beyond the infections themselves, potentially reducing the burden of the most common birth defect. For the millions of couples planning pregnancy each year, the message from this research is that the health of the next generation’s heart may begin taking shape long before the first heartbeat.

Subject of Research: Preconception maternal infection-related exposures and the risk of congenital heart disease in offspring

Article Title: Preconception maternal infection-related exposures and risk of congenital heart disease in offspring: evidence from a large population-based cohort in South China

Article References: Chen, Y., Xu, R., Wei, H., Gu, Q., Liu, Y., Zhu, J., Yang, L., Zhang, Y., & Tan, G. (2026). Preconception maternal infection-related exposures and risk of congenital heart disease in offspring: evidence from a large population-based cohort in South China. BMC Public Health. https://doi.org/10.1186/s12889-026-29782-z

Image Credits: AI Generated

DOI: 10.1186/s12889-026-29782-z

Keywords: congenital heart disease, preconception health, Chlamydia trachomatis, cytomegalovirus, rubella, Toxoplasma gondii, candidiasis, IgG seropositivity, population-based cohort, birth defects registry, maternal infection, Guangdong China

The study drew on 289 children enrolled in the PROGRESS cohort in Mexico, a long-running birth cohort designed to examine how environmental exposures shape child health. Rather than relying on blood or urine samples, which capture only recent exposure, the researchers turned to deciduous teeth, the baby teeth that children naturally shed. Teeth grow in layers much like tree rings, and the dentine that forms during specific developmental periods locks in a chemical record of what circulated in the child’s bloodstream at the time. By segmenting dentine along growth lines, the team was able to retrospectively quantify arsenic exposure for every week from sixteen weeks before birth through fourteen weeks after birth, an unprecedented temporal resolution for an immunotoxicology study.

When the children returned for a follow-up visit around age four to five, the investigators measured serum levels of immunoglobulin G antibodies directed against six vaccine antigens: measles, mumps, and rubella from the MMR vaccine, and diphtheria, tetanus, and pertussis from the DTP series. These antibodies are the immune system’s memory of vaccination, the molecular shield that prevents re-infection, and their concentrations in blood are a standard benchmark of how well a vaccine has taken hold. The measurements were performed using a multiplexed Luminex bead-based immunoassay, a technique that allows all six antibody targets to be quantified simultaneously from a small serum sample.

The statistical challenge was considerable. Because arsenic exposure was estimated for thirty consecutive weeks, the researchers needed a method that could detect when in that timeline exposure mattered, not just whether it mattered overall. They employed Distributed Lag Non-linear Models, or DLNMs, a framework originally developed in environmental epidemiology for studying delayed and time-varying effects of air pollution and temperature. The models related log2-transformed dentine arsenic concentrations to log2-transformed antibody levels across every week of the perinatal period, while adjusting for the child’s age, maternal education, parity, and child sex. The log2 transformation means the reported effects can be read as the change in antibody level associated with a doubling of arsenic exposure during a given week.

The results converged on a single, well-defined period. A doubling of arsenic exposure in the window spanning one week before birth to six weeks after birth was associated with significantly lower anti-measles antibody levels, with an estimated effect of minus 5.62 on the log2 scale and a 95 percent confidence interval running from minus 8.39 to minus 0.83. The same perinatal window showed a significant association for anti-rubella antibodies, with an effect estimate of minus 3.85 and a confidence interval from minus 6.99 to minus 0.63. In practical terms, children with higher arsenic exposure in the weeks surrounding delivery carried measurably weaker antibody defenses against measles and rubella years later, even though their vaccinations occurred long after the exposure itself.

Just as telling was what the analysis did not find. Arsenic exposure during the perinatal window showed no significant association with antibody levels against mumps, diphtheria, tetanus, or pertussis. Nor did earlier or later periods of prenatal and early postnatal exposure produce significant signals for any antigen. This selectivity is biologically intriguing. It suggests that the immune pathways supporting long-term antibody maintenance against measles and rubella may be more sensitive to arsenic’s interference than those supporting the other four antigens, or that different vaccine antigens rely on differently timed developmental programs of B-cell and plasma-cell maturation that vary in their vulnerability to toxic insult.

The timing of the susceptible window makes biological sense. The weeks surrounding birth are a period of profound immunological transition. The fetus must shift from the sterile, maternally protected environment of the womb to an microbe-rich world, and neonatal immune cells are actively learning to distinguish threat from tolerance. Maternal antibodies transferred across the placenta are waning while the infant’s own antibody production is just beginning. Arsenic is known to disrupt immune signaling, generate oxidative stress, and interfere with methylation processes that regulate gene expression, and a toxic exposure during this delicate choreography could plausibly leave a lasting imprint on how well vaccine memory is established and maintained.

The researchers also probed whether the effects differed between boys and girls, or between children who were breastfed at one month postpartum and those who were not, since both factors can shape immune development and arsenic dynamics. They found no heterogeneity by either sex or breastfeeding status, indicating that the association between perinatal arsenic and reduced measles and rubella antibodies appears to operate similarly across these subgroups. That consistency strengthens the case that the finding reflects a general biological vulnerability rather than an effect confined to a particular subset of children.

The methodological innovation deserves particular attention. Traditional exposure assessment in environmental health has long been hampered by the difficulty of reconstructing what a person was exposed to years or decades earlier. Baby teeth offer a solution that is both retrospective and precise, and their use here demonstrates how naturally shed biomaterials can transform the study of developmental toxicology. Combined with the DLNM framework, which treats exposure timing as a variable to be mapped rather than averaged, the approach allowed the team to draw a temporal map of vulnerability with weekly resolution, something conventional single-biomarker studies simply cannot achieve.

The public health implications are significant. Measles remains one of the most contagious human pathogens, and even modest reductions in population-level antibody levels can erode herd immunity and fuel outbreaks, a concern made vivid by recent resurgences of measles in countries where the disease was once controlled. Arsenic contamination of groundwater affects an estimated hundreds of millions of people worldwide, and in regions such as Mexico, where the PROGRESS cohort is based, exposure often begins before birth. If the findings are confirmed in other cohorts, they would add vaccine-preventable disease susceptibility to the long list of harms attributable to early-life arsenic exposure, and they would sharpen the argument for reducing arsenic exposure among pregnant women and newborns, whether through water filtration, dietary interventions, or regulatory limits on contaminated sources. The study, funded by the National Institutes of Health and led by researchers at the Icahn School of Medicine at Mount Sinai together with collaborators at Mexico’s National Institute of Public Health and other institutions, was published open access, with the authors reporting no competing interests.

Subject of Research: Perinatal arsenic exposure and vaccine-specific antibody levels in children

Article Title: Susceptible perinatal windows to arsenic exposure and serum antibody levels in children

Article References: Scotti, A., India-Aldana, S., Martinez, M., Arora, M., McRae, N., Lamadrid-Figueroa, H., Quataert, S. A., Estrada-Gutierrez, G., Torres-Olascoaga, L., Téllez-Rojo, M. M., Wright, R. O., Jusko, T. A., & Colicino, E. (2026). Susceptible perinatal windows to arsenic exposure and serum antibody levels in children. Environmental Health. https://doi.org/10.1186/s12940-026-01331-6

Image Credits: AI Generated

DOI: 10.1186/s12940-026-01331-6

Keywords: arsenic exposure, perinatal window, vaccine antibodies, measles, rubella, immunotoxicology, baby teeth, dentine, PROGRESS cohort, DLNM, humoral immunity, environmental health